Jean-François Rossi
Department of Haematology
University Hospital
CHU Saint Eloi
Montpellier
France
Name/email consistency: high
- Phase I study of atacicept in relapsed/refractory multiple myeloma (MM) and Waldenström's macroglobulinemia. Rossi, J.F. Clin. Lymphoma. Myeloma. Leuk (2011)
- Atacicept in relapsed/refractory multiple myeloma or active Waldenström's macroglobulinemia: a phase I study. Rossi, J.F., Moreaux, J., Hose, D., Requirand, G., Rose, M., Rouillé, V., Nestorov, I., Mordenti, G., Goldschmidt, H., Ythier, A., Klein, B. Br. J. Cancer (2009)
- Optimizing the use of anti-interleukin-6 monoclonal antibody with dexamethasone and 140 mg/m2 of melphalan in multiple myeloma: results of a pilot study including biological aspects. Rossi, J.F., Fegueux, N., Lu, Z.Y., Legouffe, E., Exbrayat, C., Bozonnat, M.C., Navarro, R., Lopez, E., Quittet, P., Daures, J.P., Rouillé, V., Kanouni, T., Widjenes, J., Klein, B. Bone Marrow Transplant. (2005)
- Efficacy and safety of oral fludarabine phosphate in previously untreated patients with chronic lymphocytic leukemia. Rossi, J.F., van Hoof, A., de Boeck, K., Johnson, S.A., Bron, D., Foussard, C., Lister, T.A., Berthou, C., Kramer, M.H., Littlewood, T.J., Marcus, R.E., Deconinck, E., Montillo, M., Guibon, O., Tollerfield, S.M. J. Clin. Oncol. (2004)









